期刊文献+

妊娠高血压疾病患者凝血相关指标的改变及临床意义 被引量:21

Change of coagulation in Patients with Hypertensive disorder complicating pregnancy
下载PDF
导出
摘要 目的通过对妊娠高血压疾病组(包括妊娠高血压组、轻度子痫前期组、重度子痫前期组)与正常晚孕组(足月)孕妇的凝血功能、血小板及血脂相关指标的检测及统计学分析比较,探讨凝血相关指标的改变与易栓症发生的相关性。方法选择62例正常晚孕组和150例妊娠期高血压疾病患者对凝血酶原时间(PT)、部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(FBG)、抗凝血酶Ⅲ(AT-Ⅲ)、凝血酶原时间国际化标准比值(PT-INR)以及血小板计数(PLT)、血小板压积(PCT)、血小板平均体积(MPV)、血小板平均分布宽度(PDW)、血脂指标甘油三酯(TG)、胆固醇(TC)进行检测和统计分析。结果妊娠高血压疾病组与正常晚孕组相比,PT、APTT、PT-INR、AT-Ⅲ、PLT值差异有统计学意义(P<0.05);FBG、MPV、PDW、TG值差异有统计学意义(P<0.05);TT、PCT、TC值各组间差异无统计学意义。结论联合检测凝血、血小板、血脂指标说明妊娠高血压疾病孕妇比正常孕妇具有更高的凝血状态,有血栓形成倾向,并且随着病情加重而加重。 Objective To investigate the connection between the change of coagulation function and thrombosis in Patients with Hypertensive disorder complicating pregnancy.Methods The PT,APTT,TT,FBG,AT-ⅢA,PT-INR,PLT,PCT,MPV,PDW and TG,TC were analyzed in 62 normal pregnant women in the third trimester and 150 pregnant women with hypertensive disorders.Results Compared with the normal pregnant women in third trimester,the level of PT,APTT,PT-INR,PLT,AT-ⅢA in the pregnant women with hypertensive disorders were obviously decreased(P〈0.05),while that of FBG,PDW,MPV,TG were significantly increased(P〈0.05).Conclusion There are thrombophilia in pregnant women with hypertensive disorders.
出处 《海南医学》 CAS 2011年第2期12-14,共3页 Hainan Medical Journal
关键词 妊娠高血压疾病 凝血功能 易栓症 血脂 Hypertensive disorder complicating pregnancy Coagulation function Thrombosis Blood lipid
  • 相关文献

参考文献8

二级参考文献17

  • 1侍庆,陈晨,王学锋,王鸿利.妊娠高血压综合征患者血浆止凝血分子标志物水平变化的意义[J].中华妇产科杂志,2004,39(11):733-736. 被引量:46
  • 2蒋维洪,毛志华,金志刚.正常妊娠和重度妊高征妇女血小板四项参数测定[J].中华妇产科杂志,1994,29(6):359-360. 被引量:23
  • 3林其德.妊高征病因学研究的进展[J].中华妇产科杂志,1997,32(1):3-5. 被引量:126
  • 4Cerneca F, Ricci G, Simeone R et al. Coagulation and fibrinolysis changes in normal pregnancy. Increased levels of procoagulants and reduced levels of inhibitors during pregnancy induce a hypercoagulable state, combined with a reactive fibrinolysis[ J]. Eur J Obstet Gynecol Reprod Biol, 1997,73:31-36
  • 5Hayashi M, Inoue T, Hoshimoto K, et al. Characterization of five marker levels of the hemostatie system and endothelial status in normotensive pregnancy and pre-eclampsia [ J ]. Eur J Haematol,2002 ,69 :297-302
  • 6VanWijk MJ, Boer K, Berckmans R J, et al. Enhanced coagulation activation in preeclampsia:the role of APC resistance, microparticles and other plasma constituents [ J ].Thromb Haemost ,2002,88:415-420
  • 7Coolman M, de Groot C J, Steegers EA, et al. Concentrations of plasminogen activators and their inhibitors in blood preconceptionally, during and after pregnancy [ J ]. Eur J Obstet Gynecol Reprod Biol,2006,128:22-28
  • 8Tanjung MT, Siddik HD, Hariman H, et al. Coagulation and fibrinolysis in preeclampsia and neonates [ J ]. Clin Appl Thromb Hemost,2005 ,11:467-73
  • 9Gao M, Nakabayashi M, Sakura M, et al The imbalance of plasminogen activators and inhibitor in preeclampsia[ J ]. J Obstet Gynaecol Res, 1996,22:9-16
  • 10张斌,庄依亮,许元初,王克强,顾继安,周国民.妊高征患者血清中内皮细胞毒性因子对内皮细胞功能的影响[J].现代妇产科进展,1998,7(2):109-112. 被引量:16

共引文献30

同被引文献176

引证文献21

二级引证文献248

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部